C07K 14/4713
Autoimmune diseases
Official title: {Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens}
C07K14/4713 (Autoimmune diseases) appears on 525 US grants and 684 published applications in this corpus.
Search patents in C07K- Granted patents
- 525
- Published applications
- 684
- Assignees
- 377
- Inventors
- 1,191
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 3 | 0 |
| 1989 | 2 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 4 | 0 |
| 1994 | 3 | 0 |
| 1995 | 7 | 0 |
| 1996 | 9 | 0 |
| 1997 | 7 | 0 |
| 1998 | 26 | 0 |
| 1999 | 30 | 0 |
| 2000 | 21 | 0 |
| 2001 | 26 | 3 |
| 2002 | 17 | 49 |
| 2003 | 21 | 83 |
| 2004 | 6 | 30 |
| 2005 | 20 | 33 |
| 2006 | 31 | 33 |
| 2007 | 23 | 27 |
| 2008 | 15 | 30 |
| 2009 | 17 | 29 |
| 2010 | 8 | 16 |
| 2011 | 13 | 19 |
| 2012 | 10 | 14 |
| 2013 | 18 | 25 |
| 2014 | 11 | 54 |
| 2015 | 23 | 26 |
| 2016 | 23 | 29 |
| 2017 | 22 | 20 |
| 2018 | 18 | 19 |
| 2019 | 16 | 23 |
| 2020 | 10 | 21 |
| 2021 | 15 | 23 |
| 2022 | 6 | 18 |
| 2023 | 9 | 8 |
| 2024 | 10 | 25 |
| 2025 | 12 | 18 |
| 2026 | 7 | 9 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods and compositions for treating skin disease with recombinant microorganisms11 Aug 2026US 12,702,684 B2Azitra Inc
- Engineered regulatory T cell2 Jun 2026US 12,643,932 B2UCL Business PLC
- Chimeric autoantibody receptor (CAAR) that binds autoantibodies targeting the central nervous system in neurological autoimmune disease5 May 2026US 12,617,835 B2Deutsches Zentrum Fur Neurodegenerative Erkrankungen E.V. (Dzne)
- Methods and compositions for enhancing functional myelin production28 Apr 2026US 12,612,636 B2Case Western Reserve University
- Methods and compositions for treating inflammatory skin disease with recombinant microorganisms10 Mar 2026US 12,569,521 B2Azitra Inc
- Modified ligand-gated ion channels and methods of use24 Sep 2026US 2026/0285926 A1Howard Hughes Medical Institute
- Biomarker levels and neuroimaging for detecting, monitoring and treating brain injury or trauma30 Jul 2026US 2026/0219284 A1Brainbox Solutions, Inc.
- In vivo production of proteins25 Jun 2026US 2026/0174909 A1ModernaTX, Inc.
- Modified ligand-gated ion channels and methods of use11 Jun 2026US 2026/0159560 A1Howard Hughes Medical Institute
- Tdp-43 mitochondrial localization inhibitor for the treatment of neurogenerative disease30 Apr 2026US 2026/0116935 A1
Most cited
By later US patents
- Albumin fusion proteins comprising GLP-1 polypeptides198US 7,141,547 B2Human Genome Sciences, Inc. · 2006
- Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins198US 9,303,079 B2Moderna Therapeutics, Inc. · 2016
- Modified polynucleotides for the production of biologics and proteins associated with human disease196US 8,999,380 B2Moderna Therapeutics, Inc. · 2015
- Modified polynucleotides for treating protein deficiency194US 9,061,059 B2Moderna Therapeutics, Inc. · 2015
- Modified polynucleotides encoding basic helix-loop-helix family member E41125US 9,107,886 B2Moderna Therapeutics, Inc. · 2015